Physician

James Michael Wages, M.D.

According to 2025 Medicare claims, James Wages, M.D. (NPI: 1447561857) practices pain management in the Shreveport-Bossier City, LA market, with the plurality of this provider's patient population coming from Caddo, LA. This provider's primary affiliated billing organization is ARKLATEX MEDICAL CONSULTANTS A MEDICAL CORPORATION (NPI: 1710466628; TIN: 830733080) and primary practice location at 71105-5682.

Wages' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 906 traditional Medicare patients, billed 7,895 HCPCS/CPT codes, and received $303,925 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,172 prescription claims across 669 beneficiaries totaling $62,399 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). DME data shows 33 claims. Open Payments data shows 17 records totaling $507. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $43,933 to $62,399. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	279	1,137	$68,663
2016	802	9,626	$474,334
2017	990	13,796	$679,830
2018	1,029	16,484	$693,753
2019	979	15,571	$580,416
2020	845	11,004	$463,130
2021	773	5,753	$355,879
2022	729	5,434	$306,585
2023	745	3,762	$292,980
2024	906	7,895	$303,925

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	281	678	$43,933
2016	514	3,085	$144,197
2017	681	4,556	$190,030
2018	728	5,064	$247,828
2019	791	4,845	$210,204
2020	677	4,084	$117,756
2021	509	2,300	$60,748
2022	517	2,234	$51,993
2023	585	2,748	$62,914
2024	669	3,172	$62,399

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	43	43	$34,138
2023	N/R	N/R	N/R
2024	33	33	$24,240

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	277	277	$126
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	221	308	$102
62323	Injection of substance into lower spine canal using imaging guidance	291	415	$77
80307	Testing for presence of drug, by chemistry analyzers	255	256	$61
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	140	228	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,407	40,778	$29,105
Pregabalin	Pregabalin	280	10,569	$9,962
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	173	5,013	$4,126
Acetaminophen-Codeine	Acetaminophen With Codeine	165	4,273	$3,730
Gabapentin	Gabapentin	378	14,000	$3,656

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L0651	Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf	N	33	33	$24,240

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$507	Nevro Corp.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Michael Wages, M.D.?

Tedicare shows public-source Medicare data for James Michael Wages, M.D. (NPI 1447561857), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Michael Wages, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Michael Wages, M.D.?

James Michael Wages, M.D. is linked to ARKLATEX MEDICAL CONSULTANTS A MEDICAL CORPORATION (billing NPI 1710466628) in the available physician profile data.

Does James Michael Wages, M.D. have Open Payments data?

James Michael Wages, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.